In the U.S., the Centers for Disease Control and Prevention reports more than 100 million adults, or about 42 percent of the population, are living with obesity, accounting for $173 billion in medical expenditures
From this perspective, MDR manifests biologically and clinically as four highly intertwined evolutionary subtypes: Firstly, de novo(primary) resistance, where tumors inherently harbor resistance mutations or exist in a profoundly immunosuppressed state, exhibiting absolute non-response from the initial treatment phase [14]
Clinical data show that nausea, vomiting, and gastrointestinal upset occur across all GLP-1 classes, but frequency and severity differ by person, formulation, and titration schedule
Actual out-of-pocket costs vary widely depending on insurance, savings programs, coupons, and the pharmacy chosen